(Q73645101)
Statements
DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy (English)
P J van de Vaart
J Belderbos
D de Jong
K C Sneeuw
D Majoor
H Bartelink
scientific article published on 01 March 2000